A detailed history of Great Lakes Advisors, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Great Lakes Advisors, LLC holds 138,118 shares of VCYT stock, worth $5.12 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
138,118
Previous 139,690 1.13%
Holding current value
$5.12 Million
Previous $3.03 Million 55.27%
% of portfolio
0.04%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$21.0 - $35.25 $33,012 - $55,413
-1,572 Reduced 1.13%
138,118 $4.7 Million
Q2 2024

Aug 05, 2024

SELL
$18.86 - $23.55 $5,412 - $6,758
-287 Reduced 0.21%
139,690 $3.03 Million
Q1 2024

May 08, 2024

BUY
$21.0 - $29.1 $2.94 Million - $4.07 Million
139,977 New
139,977 $3.1 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.65B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.